Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice

201757 citationsJournal Articlegold Open Access

Authors

Roland Rabl · QPS (Austria)

C. Breitschaedel · QPS (Austria)

Stefanie Flunkert · QPS (Austria)

Stephan Duller · QPS (Austria)

David Amschl · QPS (Austria)

Joerg Neddens · QPS (Austria)

Vera Niederkofler · QPS (Austria)

Abstract

In summary, our results strengthen and further expand our knowledge about the Line 61 mouse model, emphasizing this mouse model as a valuable in vivo tool to test new compounds directed against synucleinopathies.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Nerve injury and regeneration Nuclear Receptors and Signaling

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMC Neuroscience

Volume 18, Issue 1, pp. 22-22

DOI: 10.1186/s12868-017-0341-8

Field-Weighted Citation Impact: 2.46